Table 1.

Physician use of breast and/or ovarian cancer risk assessment and screening tools.

Family medicineInternistOB/GYNTotal
n (%)n (%)n (%)n (%)
Discussion of cancer family history
 Used246 (98.4%)235 (94.0%)246 (98.4%)727 (96.9%)
 Not used4 (1.6%)13 (5.2%)3 (1.2%)20 (2.7%)
 Not familiar with this assessment0 (0%)2 (0.8%)1 (0.4%)3 (0.4%)
Breast exam
 Used212 (84.8%)200 (80.0%)241 (96.4%)653 (87.1%)
 Not used38 (15.2%)48 (19.2%)7 (2.8%)93 (12.4%)
 Not familiar with this assessment0 (0%)2 (0.8%)2 (0.8%)4 (0.5%)
Mammogram
 Used248 (99.2%)240 (96.0%)238 (95.2%)696 (92.8%)
 Not used2 (0.8%)9 (3.6%)7 (2.8%)18 (2.4%)
 Not familiar with this assessment0 (0%)1 (0.4%)1 (0.4%)2 (0.3%)
Breast cancer risk assessment tool (e.g., Gail Model, BOADICEA, Claus, BRCAPRO, Cuzick–Tyrer)a
 Used110 (44.0%)104 (41.7%)168 (67.2%)382 (50.9%)
 Not used88 (35.2%)97 (38.8%)59 (23.6%)244 (32.5%)
 Not familiar with this assessment52 (20.8%)49 (19.6%)23 (9.2%)124 (16.5%)
Genetic testing for BRCA1 or BRCA2a
 Used114 (45.6%)128 (51.2%)202 (80.8%)444 (59.2%)
 Not used133 (53.2%)119 (47.6%)48 (19.2%)300 (40.0%)
 Not familiar with this assessment3 (1.2%)3 (1.2%)0 (0%)6 (0.8%)
Multigene testinga
 Used62 (24.8%)68 (27.2%)130 (52.0%)260 (34.7%)
 Not used146 (58.4%)153 (61.2%)101 (40.4%)400 (53.3%)
 Not familiar with this assessment42 (16.8%)29 (11.6%)19 (7.6%)90 (12.0%)
  • aIndicates significant difference between provider types (P ≤ 0.05).